Accounting for assay performance when estimating the temporal dynamics in sars-cov-2 seroprevalence in the u.s

HIGHLIGHTS

• who: Bernardo Garcu00eda-Carreras from the (UNIVERSITY) have published the article: Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S, in the Journal: (JOURNAL) of 21/07/2021
• what: Using models, the authors show that accounting for assays explains some of the observed state-to-state variation in seroprevalence, and when integrating case and death surveillance data, the authors show that when using the Abbott assay, estimates of proportions infected can differ substantially from seroprevalence estimates. u0394AIC values in the table are relative to the lowest . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.